TZP-102 Uses, Dosage, Side Effects and more
TZP-102 is under investigation in clinical trial NCT01452815 (Affects of Once-daily Oral Administration of TZP-102 on the Treatment of Symptoms Associated With Diabetic Gastroparesis).
| Trade Name | TZP-102 |
| Generic | TZP-102 |
| Type | |
| Formula | C28H44N4O4 |
| Weight | Average: 500.684 Monoisotopic: 500.336255913 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
